Assignee
EDISON PHARMACEUTICALS INC
US17 patents
Top patents by PatentIndex Score
US7968746B2Jun 28, 2011
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EDISON PHARMACEUTICALS INC46 citations97
US7514461B2Apr 7, 2009
Chroman derivatives
EDISON PHARMACEUTICALS INC59 citations97
US7470798B2Dec 30, 2008
7,8-bicycloalkyl-chroman derivatives
EDISON PHARMACEUTICALS INC60 citations97
US7432305B2Oct 7, 2008
Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
EDISON PHARMACEUTICALS INC60 citations97
US8653144B2Feb 18, 2014
Treatment of pervasive developmental disorders with redox-active therapeutics
EDISON PHARMACEUTICALS INC32 citations96
US9399612B2Jul 26, 2016
Treatment of pervasive developmental disorders with redox-active therapeutics
EDISON PHARMACEUTICALS INC12 citations92
US9370496B2Jun 21, 2016
Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
EDISON PHARMACEUTICALS INC20 citations92
US9169196B2Oct 27, 2015
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EDISON PHARMACEUTICALS INC11 citations92
US7491312B2Feb 17, 2009
Identifying therapeutic compounds based on their physical-chemical properties
EDISON PHARMACEUTICALS INC47 citations89
US9486435B2Nov 8, 2016
(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases
EDISON PHARMACEUTICALS INC7 citations84
US8969420B2Mar 3, 2015
Treatment of pervasive developmental disorders with redox-active therapeutics
EDISON PHARMACEUTICALS INC9 citations83
US9296712B2Mar 29, 2016
Resorufin derivatives for treatment of oxidative stress disorders
EDISON PHARMACEUTICALS INC12 citations82
US9629815B2Apr 25, 2017
Benzoquinone derivatives for treating oxidative stress disorders
EDISON PHARMACEUTICALS INC5 citations72
US9073873B2Jul 7, 2015
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
EDISON PHARMACEUTICALS INC4 citations72
US9090576B2Jul 28, 2015
2-substituted-p-quinone derivatives for treatment of oxidative stress diseases
EDISON PHARMACEUTICALS INC3 citations59
US9567279B2Feb 14, 2017
Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
EDISON PHARMACEUTICALS INC0 citations52
US9546132B2Jan 17, 2017
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EDISON PHARMACEUTICALS INC0 citations51